SCHEMBL961439

SCHEMBL961439

COc1cccc(CCOc2cccc(-c3cccc(C(=O)O)c3)n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 2/20 0.52
MRGPRX4 Q96LA9 3/20 0.51
LTB4R Q15722 2/20 0.51
AKR1C3 P42330 1/20 0.48
NR1H4 Q96RI1 1/20 0.47
MEP1B Q16820 1/20 0.47
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
VDR P11473 1/20 0.45
STIM1 Q13586 1/20 0.44
ORAI1 Q96D31 1/20 0.44
HIF1A Q16665 1/20 0.44
AURKA O14965 1/20 0.43
KDM6B O15054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL958255 0.89 GPR52 (0.56) GPR52LTB4RNR1H4TP53AURKA
SCHEMBL958231 0.87 GPR52 (0.53) GPR52MRGPRX4LTB4RAKR1C3NR1H4
SCHEMBL3402485 0.86 GPR52 (0.61) GPR52TP53RAB9AAURKAMMP13
SCHEMBL957828 0.86 PTGDR (0.55) GPR52MRGPRX4PKM
SCHEMBL961206 0.86 GPR52 (0.63) GPR52TP53RAB9ASMN1; SMN2AURKA
SCHEMBL959859 0.85 GPR52 (0.73) GPR52TP53RAB9AAURKAMMP13
SCHEMBL958328 0.84 GPR52 (0.57) GPR52MRGPRX4LTB4RNR1H4KDM5A
SCHEMBL12918938 0.84 GPR52 (0.61) GPR52TP53RAB9AAURKAMMP13
Hydrochloric Acid SCHEMBL958163 0.83 GPR52 (0.60) GPR52TP53RAB9AAURKAMMP13
SCHEMBL13070873 0.83 TAS1R3 (0.60) GPR52AURKAMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 GPR52 23/4885MRGPRX4 133/4885LTB4R 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.